1. Home
  2. OLED vs ADMA Comparison

OLED vs ADMA Comparison

Compare OLED & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

OLED

Universal Display Corporation

HOLD

Current Price

$124.50

Market Cap

5.7B

Sector

Technology

ML Signal

HOLD

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

HOLD

Current Price

$17.57

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OLED
ADMA
Founded
1985
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.7B
4.7B
IPO Year
1992
N/A

Fundamental Metrics

Financial Performance
Metric
OLED
ADMA
Price
$124.50
$17.57
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
2
Target Price
$177.60
$28.50
AVG Volume (30 Days)
502.0K
2.2M
Earning Date
02-19-2026
03-02-2026
Dividend Yield
1.43%
N/A
EPS Growth
N/A
205.35
EPS
4.64
0.86
Revenue
$639,977,000.00
$488,559,000.00
Revenue This Year
$2.50
$22.19
Revenue Next Year
$10.90
$23.71
P/E Ratio
$27.15
$20.95
Revenue Growth
N/A
27.63
52 Week Low
$103.70
$13.50
52 Week High
$164.29
$25.67

Technical Indicators

Market Signals
Indicator
OLED
ADMA
Relative Strength Index (RSI) 55.48 40.28
Support Level $121.83 $16.24
Resistance Level $126.60 $18.95
Average True Range (ATR) 2.69 0.70
MACD 0.93 -0.22
Stochastic Oscillator 63.01 37.22

Price Performance

Historical Comparison
OLED
ADMA

About OLED Universal Display Corporation

Universal Display Corp researches, develops, and manufactures organic light-emitting diode, or OLED, technologies for use in displays for mobile phones, tablets, televisions, wearables, personal computers, automotive interiors, and the solid-state lighting market. OLED technologies are an alternative to light-emitting diode, or LED, technologies, in the solid-state lighting market, and liquid crystal displays in the flat-panel-display market. The Company has one reportable business segment being OLED technologies and materials. A large majority of the firm's revenue is generated in South Korea, with the rest coming from Japan, China, the United States, and other countries across the world.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

Share on Social Networks: